APA (7th ed.) Citation

Rachel C. Ruda, Katherine A. Kelly, & Steven R. Feldman. (2023). Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Rachel C. Ruda, Katherine A. Kelly, and Steven R. Feldman. Real-world Outcomes Following Switching from Anti-TNF Reference Products to Biosimilars for the Treatment of Psoriasis. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Rachel C. Ruda, et al. Real-world Outcomes Following Switching from Anti-TNF Reference Products to Biosimilars for the Treatment of Psoriasis. Taylor & Francis Group, 2023.